Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial

Go back to Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
(NASDAQ: MDXH) Delayed: 0.70 --0 (-0%)
Previous Close $0.70    52 Week High
Open $0.70    52 Week Low
Day High $0.70    P/E N/A 
Day Low $0.70    EPS
Volume 43